P
Pieter Willem Kamphuisen
Researcher at University of Amsterdam
Publications - 100
Citations - 7028
Pieter Willem Kamphuisen is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Pulmonary embolism & Thrombosis. The author has an hindex of 36, co-authored 100 publications receiving 6411 citations. Previous affiliations of Pieter Willem Kamphuisen include Radboud University Nijmegen Medical Centre & University of Perugia.
Papers
More filters
Journal ArticleDOI
Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study
Benjamin F. Voight,Benjamin F. Voight,Benjamin F. Voight,Gina M. Peloso,Gina M. Peloso,Marju Orho-Melander,Ruth Frikke-Schmidt,Maja Barbalić,Majken K. Jensen,George Hindy,Hilma Holm,Eric L. Ding,Toby Johnson,Heribert Schunkert,Nilesh J. Samani,Nilesh J. Samani,Robert Clarke,Jemma C. Hopewell,John F. Thompson,Mingyao Li,Gudmar Thorleifsson,Christopher Newton-Cheh,Kiran Musunuru,Kiran Musunuru,James P. Pirruccello,James P. Pirruccello,Danish Saleheen,Li Chen,Alexandre F.R. Stewart,Arne Schillert,Unnur Thorsteinsdottir,Unnur Thorsteinsdottir,Gudmundur Thorgeirsson,Sonia S. Anand,James C. Engert,Thomas M. Morgan,John A. Spertus,Monika Stoll,Klaus Berger,Nicola Martinelli,Domenico Girelli,Pascal P. McKeown,Christopher Patterson,Stephen E. Epstein,Joseph M. Devaney,Mary Susan Burnett,Vincent Mooser,Samuli Ripatti,Ida Surakka,Markku S. Nieminen,Juha Sinisalo,Marja-Liisa Lokki,Markus Perola,Aki S. Havulinna,Ulf de Faire,Bruna Gigante,Erik Ingelsson,Tanja Zeller,Philipp S. Wild,Paul I.W. de Bakker,Olaf H. Klungel,Anke-Hilse Maitland-van der Zee,Bas J M Peters,Anthonius de Boer,Diederick E. Grobbee,Pieter Willem Kamphuisen,Vera H.M. Deneer,Clara C. Elbers,N. Charlotte Onland-Moret,Marten H. Hofker,Cisca Wijmenga,W. M. Monique Verschuren,Jolanda M. A. Boer,Yvonne T. van der Schouw,Asif Rasheed,Philippe M. Frossard,Serkalem Demissie,Serkalem Demissie,Cristen J. Willer,Ron Do,Jose M. Ordovas,Jose M. Ordovas,Gonçalo R. Abecasis,Michael Boehnke,Karen L. Mohlke,Mark J. Daly,Mark J. Daly,Candace Guiducci,Noël P. Burtt,Aarti Surti,Elena Gonzalez,Shaun Purcell,Shaun Purcell,Stacey Gabriel,Jaume Marrugat,John F. Peden,Jeanette Erdmann,Patrick Diemert,Christina Willenborg,Inke R. König,Marcus Fischer,Christian Hengstenberg,Andreas Ziegler,Ian Buysschaert,Diether Lambrechts,Frans Van de Werf,Keith A.A. Fox,Nour Eddine El Mokhtari,Diana Rubin,Jürgen Schrezenmeir,Stefan Schreiber,Arne Schäfer,John Danesh,Stefan Blankenberg,Robert Roberts,Ruth McPherson,Hugh Watkins,Alistair S. Hall,Kim Overvad,Eric B. Rimm,Eric Boerwinkle,Anne Tybjærg-Hansen,L. Adrienne Cupples,L. Adrienne Cupples,Muredach P. Reilly,Olle Melander,Pier Mannuccio Mannucci,Diego Ardissino,David S. Siscovick,Roberto Elosua,Kari Stefansson,Kari Stefansson,Christopher J. O'Donnell,Christopher J. O'Donnell,Veikko Salomaa,Daniel J. Rader,Leena Peltonen,Leena Peltonen,Stephen M. Schwartz,David Altshuler,Sekar Kathiresan +140 more
TL;DR: In this paper, a Mendelian randomisation analysis was performed to compare the effect of HDL cholesterol, LDL cholesterol, and genetic score on risk of myocardial infarction.
Journal ArticleDOI
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
Elise S. Eerenberg,Pieter Willem Kamphuisen,Meertien K. Sijpkens,Joost C. M. Meijers,Harry R. Büller,Marcel Levi +5 more
TL;DR: In this article, the authors evaluated the potential of prothrombin complex concentrate (PCC) to reverse the anticoagulant effect of Rivaroxaban and dabigatran.
Journal ArticleDOI
Elevated factor VIII levels and the risk of thrombosis.
TL;DR: Despite growing insight in the pathogenesis of thrombophilia, the cause of manyThrombotic episodes remains unknown and genetic risk factors involved are still uncertain.
Journal ArticleDOI
Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions.
Pieter Willem Kamphuisen,Jeroen Eikenboom,Hans L. Vos,Renee Pablo,Auguste Sturk,Rogier M. Bertina,Frits R. Rosendaal +6 more
TL;DR: Results show that although systemic inflammation may be present in some of the patients, elevated levels of factor VIII:C and fibrinogen were in general not caused by acute phase reactions, which further supports a causal relationship between both high factor VIII-C levels and fibinogen levels and venous thrombosis.
Journal ArticleDOI
Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: A systematic review
Federico Lussana,Sabrina Caberlon,Chiara Pagani,Pieter Willem Kamphuisen,Harry R. Büller,Marco Cattaneo +5 more
TL;DR: V617F Jak-2 increases the risk of thrombosis in essentialThrombocythaemia patients by about two fold while its role in idiopathic myelofibrosis patients is uncertain.